|
By Pam Perry
One of the country's first three Core Centers of Excellence in Molecular Hematology has been established at the IU School of Medicine (IUSM) through a $4.7 million grant from the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), a part of the National Institutes of Health.
The grant will support basic science research, and the application of this research in clinical trials using gene therapy for childhood leukemias, adult and child cancers, and a variety of genetic blood diseases and metabolic disorders. These blood and blood-related diseases are likely to be among the first maladies treated by gene therapy, because blood is extremely accessible.
The new grant supports five shared "high-tech" facilities at IUSM, also called cores, that can be used by many researchers as they work to uncover the underlying causes of blood and blood-related diseases.
Read more at this Web site:
Return to Table of Contents